Analysis and Perspective: Comparison of Insulin Diluent Leakage Post-Injection Using Two Different Needle Lengths and Injection Volumes in Obese Patients with Type 1 or Type 2 Diabetes Mellitus
Free accessResearch articleFirst published online March, 2012
Analysis and Perspective: Comparison of Insulin Diluent Leakage Post-Injection Using Two Different Needle Lengths and Injection Volumes in Obese Patients with Type 1 or Type 2 Diabetes Mellitus
The effects of needle gauge and length on the efficacy and tolerability of insulin injection therapy are becoming better understood. This analysis discusses some of these effects and comments on a new study by Ignaut and Fu in this issue of Journal of Diabetes Science and Technology on the effects of needle length on insulin diluent leakage from injection sites.
PolonskyWHHajosTRDainMPSnoekFJ. Are patients with type 2 diabetes reluctant to start insulin therapy? An examination of the scope and underpinnings of psychological insulin resistance in a large, international population. Curr Med Res Opin.2011; 27 (6): 1169–74.
FridAHirschLGasparRHicksDKreugelGLierschJLetondeurCSauvanetJPTubiana-RufiNStraussK; Scientific Advisory Board for the Third Injection Technique Workshop. New injection recommendations for patients with diabetes. Diabetes Metab.2010; 36Suppl 2: S3–18.
4.
LuijfYMDeVriesJH. Dosing accuracy of insulin pens versus conventional syringes and vials. Diabetes Technol Ther.2010; 12Suppl 1: S73–7.
5.
BaileyTThurmanJNiemeyerMSchmeislG. Usability and preference evaluation of a prefilled insulin pen with a novel injection mechanism by people with diabetes and healthcare professionals. Curr Med Res Opin.2011; 27 (10): 2043–52.
6.
GibneyMAArceCHByronKJHirschLJ. Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: Implications for needle length recommendations. Curr Med Res Opin.2010; 26 (6): 1519–30.
7.
Tubiana-RufiNBelarbiNDu Pasquier-FediaevskyLPolakMKakouBLeridonLHassanMCzernichowP. Short needles (8 mm) reduce the risk of intramuscular injections in children with type 1 diabetes. Diabetes Care.1999; 22 (10): 1621–5.
8.
WittmannAKöverJKraljNGasthausKLerchHRommelMMosesSHofmannF. Insulin leakage value in relation to pen needle length and administered dose after subcutaneous injection. Diabetes Technol Ther.2010; 12 (8): 587–90.
9.
JuulK Ann PraestmarkBengtssonHEyvingBKildegaardJLavSPoulsenMSerupJStallknechtB. Influence of hypodermic needle dimensions on subcutaneous injection delivery — A pig study of injection deposition evaluated by CT scanning, histology, and backflow. Skin Res Technol.2012. Epub ahead of print.
10.
HirschLJGibneyMAAlbaneseJQuSKassler-TaubKKlaffLJBaileyTS. Comparative glycemic control, safety and patient ratings for a new 4 mm × 32G insulin pen needle in adults with diabetes. Curr Med Res Opin.2010; 26 (6): 1531–41.
11.
SchwartzSHassmanDShelmetJSieversRWeinsteinRLiangJLynessW. A multicenter, open-label, randomized, two-period crossover trial comparing glycemic control, satisfaction, and preference achieved with a 31 gauge × 6 mm needle versus a 29 gauge × 12.7 mm needle in obese patients with diabetes mellitus. Clin Ther.2004; 26 (10): 1663–78.
12.
IgnautDAFuH. Comparison of insulin diluent leakage postinjection using two different needle lengths and injection volumes in obese patients with type 1 or type 2 diabetes mellitus. J Diabetes Sci Technol.2012; 6 (2): 389–93.
